KBL is a venture capital firm dedicated to investing in early stage and emerging growth healthcare companies. Their goal is to identify companies that are run by seasoned management teams and that have the potential to create long term value. They feel that the convergence of biology, chemistry, physics and computer science will spark the creation of several new paradigms within healthcare. Major areas of investment include life sciences, medical devices, healthcare services and medical information technology. Within the life sciences space, they will invest in biopharmaceuticals, drug discovery platforms and advanced materials. Within the medical device area, they seek companies addressing large, unmet medical needs with demonstrated clinical benefit.
| Company | Date | Round | Size | Participants |
| CardioFocus | 2/11 | Series C | $30.6M | 9 |
| Neuronetics | 10/09 | Series D | $30M | 7 |
